Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
13.42
0.00 (0.00%)
At close: May 19, 2026, 4:00 PM EDT
13.41
-0.01 (-0.07%)
After-hours: May 19, 2026, 7:10 PM EDT
Organon & Co. Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Organon & Co. stock has a consensus rating of "Hold" and an average price target of $11.25. The average 1-year stock price forecast is 16.17% lower than the current stock price, while the lowest is $8.00 (-40.39%) and the highest is $14 (+4.32%).
Price Target: $11.25 (-16.17%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Organon & Co. stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 1 | 1 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 3 | 3 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BNP Paribas | BNP Paribas | Buy → Hold Downgrades $12 → $14 | Buy → Hold | Downgrades | $12 → $14 | +4.32% | Apr 29, 2026 |
| Piper Sandler | Piper Sandler | Sell → Hold Upgrades $5 → $14 | Sell → Hold | Upgrades | $5 → $14 | +4.32% | Apr 28, 2026 |
| Barclays | Barclays | Sell Maintains $7.5 → $8 | Sell | Maintains | $7.5 → $8 | -40.39% | Feb 24, 2026 |
| Barclays | Barclays | Sell Initiates $7.5 | Sell | Initiates | $7.5 | -44.11% | Dec 9, 2025 |
| JP Morgan | JP Morgan | Sell Maintains $14 → $12 | Sell | Maintains | $14 → $12 | -10.58% | Nov 11, 2025 |
Financial Forecast
Revenue This Year
6.22B
from 6.22B
Increased by 0.03%
Revenue Next Year
6.31B
from 6.22B
Increased by 1.46%
EPS This Year
3.49
from 0.72
Increased by 384.34%
EPS Next Year
3.72
from 3.49
Increased by 6.75%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 6.5B | 6.8B | |||||
| Avg | 6.2B | 6.3B | |||||
| Low | 5.9B | 5.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 4.8% | 8.7% | |||||
| Avg | 0.0% | 1.5% | |||||
| Low | -5.3% | -5.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 3.91 | 4.14 | |||||
| Avg | 3.49 | 3.72 | |||||
| Low | 3.23 | 3.34 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 442.5% | 18.6% | |||||
| Avg | 384.3% | 6.7% | |||||
| Low | 349.2% | -4.2% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.